Articles by admin

…read more […]

“The days of $100 oil are over,” says Bubba Trading founder and CEO Todd Horwitz. …read more […]

(Bloomberg) — Wirecard AG, one of Europe’s largest fintech firms as recently as two weeks ago, collapsed in an accounting scandal that’s pushed the company to file for insolvency. So why is it the best performer in Germany’s benchmark DAX Index this week?On Friday the stock was down 99% for the year. In the two trading sessions since Friday’s low, shares in the scandal-ridden payments provider have risen more than fourfold, with more than 36 million shares changing hands in each session — more than 10 times the past year’s average. It’s an echo of the bizarre trading this month …read more […]

Wells Fargo is the first big bank to cut its dividend following the Federal Reserve’s restrictions …read more […]

The resurgence of cases affecting more than half of U.S. states and territories stoked more worries among health experts on Tuesday. …read more […]

Markets have an annoying habit of proving investors wrong. That’s what makes contrarian indicators so powerful.
Today, Nicholas Vardy shares his favorite contrarian indicator… and how it can help you make better investing decisions.

“Bull markets are born on pessimism, grown on skepticism, mature on optimism and die on euphoria.”
– Sir John Templeton
Like the late Sir John Templeton, I’m a big fan of contrarian indicators.
That’s because financial markets have an annoying habit of proving investors wrong.
And they do so precisely when it will cost the largest number of investors the most money.
That’s what makes contrarian indicators such powerful tools.

Click here to watch …read more […]

The lessor, which is based in Singapore and listed in Hong Kong, will also defer the delivery of some other Boeing 737 MAX aircraft, it said in a statement. BOC is the latest lessor to strike deals with Boeing to cancel 737 MAX orders as the jet remains grounded pending regulatory approval following two crashes. “We discussed with Boeing what is the best way to deploy our capital in a time like this because everyone realises this is not a short term downturn, it is a long one,” BOC Aviation Chief Executive Robert Martin told Reuters. …read more […]

The coronavirus has had a devastating effect on a plethora of industries, with cruise operators amongst the most badly hit.The recent spike in coronavirus cases has sown further uncertainty. Timelines for the resumption of sailings have been pushed back further into the unknown, raising even more concern regarding the industry’s future. Yet, this is precisely why Tigress Financial analyst Ivan Feinseth believes the time is right to consider an investment in the world’s largest cruise operator Carnival (CCL).The 5-star analyst reiterated a Buy rating on CCL “as it will overcome COVID-19 pandemic headwinds, and the pullback in the stock creates …read more […]

(Bloomberg) — Tesla Inc.’s market value has surpassed Exxon Mobil Corp.’s in a sign that investors are increasingly betting on a global energy transition away from fossil fuels.Elon Musk’s Tesla, now at $201 billion in market capitalization, is surging on the billionaire founder’s optimism that his company can avoid a second-quarter loss. Exxon, which dropped to $185 billion, is reeling from the worst crude-price crash in history. The largest oil company in the Western Hemisphere is preparing to cut some of its U.S. workforce.Tesla also is on the verge of passing Toyota Motor Corp. to become the most valuable automaker …read more […]

New COVID-19 cases are surging in the U.S. as WHO warns ‘the worst is yet to come’. Yahoo Finance’s On The Move panel discusses. …read more […]

ROBO Global Senior Research Analyst Nina Deka joins Yahoo Finance’s On The Move panel to address the dangers of chasing coronavirus vaccine stocks. …read more […]

Gold prices could stay on a hot streak. Here’s why this gold industry insider thinks so. …read more […]

Inovio Pharmaceuticals (INO) on Tuesday announced “positive” interim clinical data results of INO-4800, its experimental vaccine candidate against the novel coronavirus.Shares, however dropped 12% to $27.74 in midday U.S. trading, suggesting investors were taking the results with a grain of salt. The value of the stock has this year already ballooned 740%.Inovio said that the early-stage clinical data demonstrated that INO-4800 resulted in immune responses and was generally safe and well-tolerated in all participants in the first two Phase 1 trial cohorts. In addition, the biotech company announced that INO-4800 has been selected to participate in a non-human primate (NHP) …read more […]